{{PBB|geneid=183}}
{{noteTA
|G1=生命科学
|T=zh-cn:血管紧张素; zh-tw:血管收縮素; 
|1=zh-cn:血管紧张素; zh-tw:血管收縮素; 
}}
'''血管收縮素'''（Angiotensin），亦称'''-{zh-cn:血管收缩素;zh-tw:血管緊張素;}-'''、'''血管緊縮素'''、'''血管張力素'''，是一种寡肽类激素，是[[腎素-血管收縮素系统|腎素-血管收縮素系统]]（renin-angiotensin system）的重要组成部分。血管紧张素能引起血管收缩，升高血压；促进[[肾上腺皮质|肾上腺皮质]]释放[[醛固酮|醛固酮]]。它也具有很强的[[致渴作用|致渴作用]]。血管紧张素的前体是由肝脏合成的一种血清[[球蛋白|球蛋白]]：[[血管紧张素原|血管紧张素原]]。血管紧张素最早于20世纪30年代末由[[美国|美国]][[印第安纳|印第安纳]]和[[阿根廷|阿根廷]]的研究人员分别独立分离，并被分别命名为Angiotonin和Hypertensin，后来被美国[[克利夫兰诊所|克利夫兰诊所]]和[[瑞士|瑞士]][[巴塞尔|巴塞尔]]的[[汽巴|汽巴]]实验室（Ciba Laboratories）描述并合成。<ref>{{cite journal |author=Basso N, Terragno NA |title=History about the discovery of the renin-angiotensin system |journal=Hypertension |volume=38 |issue=6 |pages=1246–9 |pmid=11751697 |doi= |url=http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=11751697 |date=2001年12月 }}{{Dead link|date=2019年5月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>

== 前体及种类 ==
[[File:Ras_system.png|thumb]]
=== 血管紧张素原 ===

血管紧张素原是一种主要由肝脏持续合成并释放入血液循环的α-2球蛋白。它属于[[丝氨酸蛋白酶抑制物超家族|丝氨酸蛋白酶抑制物超家族]]（'''ser'''ine '''p'''rotease '''in'''hibitors，[[serpin|serpin]]），虽然就目前所知它不能抑制任何酶的活性。皮质激素、雌激素、甲状腺素和血管紧张素II可增高血浆血管紧张素原含量。

血管紧张素原是[[肾素|肾素]]的底物。

人血管紧张素原包含452个[[氨基酸残基|氨基酸残基]]，而其他物种的血管紧张素原大小有所不同。它的N-端12个氨基酸残基由于关系到其活性而最为重要。

 '''Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile'''
<ref>{{Cite web |url=http://www.ncbi.nlm.nih.gov/ |title=NCBI HomePage<!-- Bot generated title --> |access-date=2021-05-15 |archive-date=2018-01-28 |archive-url=https://web.archive.org/web/20180128064002/http://www.ncbi.nlm.nih.gov/ |dead-url=no }}</ref>

=== 血管紧张素Ⅰ ===

 '''Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu'''

血管紧张素Ⅰ由[[肾素|肾素]]作用于血管紧张素原形成。肾素能催化血管紧张素原[[亮氨酸|亮氨酸]]（Leu）与[[缬氨酸|缬氨酸]]（Val）间的肽键水解产生十肽血管紧张素I；

血管紧张素Ⅰ基本没有生物学活性，而是作为血管紧张素Ⅱ的前体存在。

=== 血管紧张素Ⅱ ===
{{main|血管紧张素II}}
 '''Asp-Arg-Val-Tyr-Ile-His-Pro-Phe''' | His-Leu

血管紧张素I经[[血管紧张素Ⅰ转化酶|血管紧张素Ⅰ转化酶]]剪切C-末端两个氨基酸残基而形成血管紧张素Ⅱ。血管紧张素II是一种可通过[[内分泌|内分泌]]、[[自分泌|自分泌]]/[[旁分泌|旁分泌]]以及[[胞内分泌|胞内分泌]]发挥作用的[[激素|激素]]。

血管紧张素Ⅱ通过[[谷氨酰氨基肽酶|血管紧张素酶]]降解为血管紧张素Ⅲ，其在循环系统的[[半衰期|半衰期]]约为30秒，而在组织中最长可达15至30分钟。

=== 血管紧张素Ⅲ ===

 Asp | '''Arg-Val-Tyr-Ile-His-Pro-Phe'''

相比较血管紧张素Ⅱ而言，血管紧张素Ⅲ（七肽）仍具有40%的升压活性和100%的促[[醛固酮|醛固酮]]分泌活性。

=== 血管紧张素Ⅳ ===

 Arg | '''Val-Tyr-Ile-His-Pro-Phe'''

血管紧张素Ⅳ（六肽）与血管紧张素Ⅲ相似，而活性更低。

=== 血管紧张素-(1-9) ===

 '''Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His''' |-Leu

=== 血管紧张素-(1-7) ===

 '''Asp-Arg-Val-Tyr-Ile-His-Pro'''|-Phe

== 参考文献 ==
{{Reflist}}

==延伸閲讀==
{{refbegin | 2}}
* {{cite journal | vauthors = de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T | title = International union of pharmacology. XXIII. The angiotensin II receptors | journal = Pharmacological Reviews | volume = 52 | issue = 3 | pages = 415–72 | date = September 2000 | pmid = 10977869 }}
*''Brenner & Rector's The Kidney'', 7th ed., Saunders, 2004.
*''Mosby's Medical Dictionary'', 3rd Ed., CV Mosby Company, 1990.
*''Review of Medical Physiology'', 20th Ed., William F. Ganong, McGraw-Hill, 2001.
*''Clinical Physiology of Acid-Base and Electrolyte Disorders'', 5th ed., Burton David Rose & Theodore W. Post McGraw-Hill, 2001
* {{cite journal | vauthors = Lees KR, MacFadyen RJ, Doig JK, Reid JL | title = Role of angiotensin in the extravascular system | journal = Journal of Human Hypertension | volume = 7 Suppl 2 | issue =  | pages = S7-12 | date = August 1993 | pmid = 8230088 | doi =  }}
* {{cite journal | vauthors = Weir MR, Dzau VJ | title = The renin-angiotensin-aldosterone system: a specific target for hypertension management | journal = American Journal of Hypertension | volume = 12 | issue = 12 Pt 3 | pages = 205S–213S | date = December 1999 | pmid = 10619573 | doi = 10.1016/S0895-7061(99)00103-X }}
* {{cite journal | vauthors = Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG | title = Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide | journal = American Journal of Physiology. Heart and Circulatory Physiology | volume = 281 | issue = 6 | pages = H2337-65 | date = December 2001 | pmid = 11709400 | doi = 10.1152/ajpheart.2001.281.6.H2337 }}
* {{cite journal | vauthors = Sernia C | title = A critical appraisal of the intrinsic pancreatic angiotensin-generating system | journal = Journal of the Pancreas | volume = 2 | issue = 1 | pages = 50–5 | date = January 2001 | pmid = 11862023 | doi =  }}
* {{cite journal | vauthors = Varagic J, Frohlich ED | title = Local cardiac renin-angiotensin system: hypertension and cardiac failure | journal = Journal of Molecular and Cellular Cardiology | volume = 34 | issue = 11 | pages = 1435–42 | date = November 2002 | pmid = 12431442 | doi = 10.1006/jmcc.2002.2075 }}
* {{cite journal | vauthors = Wolf G | title = Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis | journal = Antioxidants & Redox Signaling | volume = 7 | issue = 9–10 | pages = 1337–45 | year = 2006 | pmid = 16115039 | doi = 10.1089/ars.2005.7.1337 }}
* {{cite journal | vauthors = Cazaubon S, Deshayes F, Couraud PO, Nahmias C | title = [Endothelin-1, angiotensin II and cancer] | journal = Médecine/Sciences | volume = 22 | issue = 4 | pages = 416–22 | date = April 2006 | pmid = 16597412 | doi = 10.1051/medsci/2006224416 | url = http://www.medecinesciences.org/10.1051/medsci/2006224416/pdf }}
* {{cite journal | vauthors = Ariza AC, Bobadilla NA, Halhali A | title = [Endothelin 1 and angiotensin II in preeeclampsia] | journal = Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion | volume = 59 | issue = 1 | pages = 48–56 | year = 2007 | pmid = 17569300 | doi =  }}
{{refend}}

== 参见 ==
*[[肾素-血管紧张素系统|肾素-血管紧张素系统]]
*[[肾素|肾素]]
*[[血管紧张素转化酶|血管紧张素转化酶]]
*[[血管紧张素受体|血管紧张素受体]]

==外部連結==
{{commons category|Angiotensin}}
* The [[MEROPS|MEROPS]] online database for peptidases and their inhibitors: [http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=I04.953 I04.953] {{Wayback|url=http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=I04.953 |date=20191016155606 }}
* {{MeshName|Angiotensins}}
* {{UCSC gene info|AGT}}
* {{PDBe-KB2|P01019|Angiotensin}}

{{Cardiovascular physiology}}
{{tsl|en|Template:Angiotensin receptor modulators}}
{{神经肽}}
{{Peptidergics}}
{{自身活性物质}}
{{Authority control}}

[[Category:肽类激素|Category:肽类激素]]
[[Category:脉管学|Category:脉管学]]
[[Category:内分泌学|Category:内分泌学]]